Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in IOVA held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 37.0M | $153.7M | +18.9% | 8.277% | 0.00% |
| 2 | MHR FUND MANAGEMENT LLC | 29.0M | $120.5M | 0.0% | 6.488% | 6.28% |
| 3 | STATE STREET CORP | 24.5M | $101.8M | +40.3% | 5.482% | 0.00% |
| 4 | TWO SIGMA INVESTMENTS, LP | 19.0M | $79.1M | +38.9% | 4.258% | 0.06% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 18.2M | $75.7M | +9.6% | 4.077% | 0.00% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 14.4M | $59.9M | +23.0% | 3.223% | 0.00% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 10.3M | $43.0M | +20.4% | 2.312% | 0.00% |
| 8 | MILLENNIUM MANAGEMENT LLC | 8.5M | $35.5M | -9.4% | 1.909% | 0.01% |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 7.7M | $32.1M | +15.2% | 1.728% | 0.00% |
| 10 | DIMENSIONAL FUND ADVISORS LP | 6.5M | $26.9M | +144.2% | 1.447% | 0.00% |
| 11 | JANE STREET GROUP, LLC | 5.5M | $22.8M | +16.9% | 1.225% | 0.00% |
| 12 | Palo Alto Investors LP | 5.3M | $22.0M | -16.6% | 1.186% | 1.01% |
| 13 | GOLDMAN SACHS GROUP INC | 5.1M | $21.2M | -41.8% | 1.141% | 0.00% |
| 14 | Nuveen, LLC | 5.0M | $20.8M | +36.4% | 1.119% | 0.00% |
| 15 | BANK OF AMERICA CORP /DE/ | 5.0M | $20.8M | -41.2% | 1.118% | 0.00% |
| 16 | MORGAN STANLEY | 5.0M | $20.7M | -19.6% | 1.117% | 0.00% |
| 17 | JUPITER ASSET MANAGEMENT LTD | 4.5M | $18.9M | β | 1.016% | 0.09% |
| 18 | NORTHERN TRUST CORP | 4.2M | $17.3M | +44.5% | 0.930% | 0.00% |
| 19 | AQR CAPITAL MANAGEMENT LLC | 3.9M | $16.1M | +520.0% | 0.867% | 0.01% |
| 20 | CITADEL ADVISORS LLC | 3.6M | $15.1M | -5.8% | 0.815% | 0.00% |
| 21 | WELLS FARGO & COMPANY/MN | 3.2M | $13.5M | +56.7% | 0.727% | 0.00% |
| 22 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.2M | $13.4M | +15.7% | 0.721% | 0.00% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 2.5M | $10.6M | +16.4% | 0.570% | 0.00% |
| 24 | JPMORGAN CHASE & CO | 2.4M | $10.2M | -2.8% | 0.545% | 0.00% |
| 25 | D. E. Shaw & Co., Inc. | 2.1M | $8.9M | -73.3% | 0.480% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in IOVA β a direct measure of their conviction.
Filings activity in IOVA during Q2 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 289 | +1.8% | 65.80% | +2.19 pp | $1.19B | +28% |
| Q1 2026 | 284 | +8.8% | 63.61% | 1.76 pp | $931M | +32% |
| Q4 2025 | 261 | +6.5% | 65.37% | +8.41 pp | $705M | +53% |
| Q3 2025 | 245 | 1.2% | 56.96% | 7.34 pp | $460M | +26% |
| Q2 2025 | 248 | 16% | 64.30% | 8.21 pp | $364M | 52% |
| Q1 2025 | 294 | 0.7% | 72.51% | 7.34 pp | $764M | 65% |
| Q4 2024 | 296 | +5.7% | 79.85% | +2.43 pp | $2.20B | +6.5% |
| Q3 2024 | 280 | β | 77.42% | β | $2.06B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying IOVA stock.
Based on Q2 2026 13F filings, institutional ownership of Iovance Biotherapeutics, Inc. stands at 65.8%, held across 289 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of IOVA, with approximately 36,957,681 shares worth $0.15B as of Q2 2026.
Yes β 5 widely-followed marquee investors appear among the top 25 institutional holders of IOVA, including TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JANE STREET GROUP, LLC, CITADEL ADVISORS LLC.
Our composite Smart Money Score for IOVA is 78 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
40 institutions opened new positions in IOVA during Q2 2026, while 37 fully exited. 199 added to existing positions and 39 trimmed.
IOVA institutional ownership rose by 2.19 percentage points quarter-over-quarter, with a net change of +5 holders.
The top 10 institutions account for 61.3% of all reported 13F value in IOVA, and the top 25 account for 82.6%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Iovance Biotherapeutics, Inc. (IOVA) Institutional Ownership